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Diagnostic Category Prevalence in 3 Classification Systems Across the Transition
to the International Classification of Diseases, Tenth Revision, Clinical Modification
Randall P. Ellis, PhD; Heather E. Hsu, MD, MPH; Chenlu Song, MA; Tzu-Chun Kuo, PhD; Bruno Martins, PhD; Jeffrey J. Siracuse, MD, MBA; Ying Liu, MA; Arlene S. Ash, PhD
Abstract
IMPORTANCE On October 1, 2015, the US transitioned to the International Classification of Diseases,
Tenth Revision, Clinical Modification (ICD-10-CM) for recording diagnoses, symptoms, and
procedures. It is unknown whether this transition was associated with changes in diagnostic category
prevalence based on diagnosis classification systems commonly used for payment and quality
reporting.
OBJECTIVE To assess changes in diagnostic category prevalence associated with the ICD-10-CM
transition.
DESIGN, SETTING, AND PARTICIPANTS This interrupted time series analysis and cross-sectional
study examined level and trend changes in diagnostic category prevalence associated with the
ICD-10-CM transition and clinically reviewed a subset of diagnostic categories with changes of 20%
or more. Data included insurance claim diagnoses from the IBM MarketScan Commercial Database
from January 1, 2010, to December 31, 2017, for more than 18 million people aged 0 to 64 years with
private insurance. Diagnoses were mapped using 3 common diagnostic classification systems: World
Health Organization (WHO) disease chapters, Department of Health and Human Services
Hierarchical Condition Categories (HHS-HCCs), and Agency for Healthcare Research and Quality
Clinical Classification System (AHRQ-CCS). Data were analyzed from December 1, 2018, to January
21, 2020.
EXPOSURES US implementation of ICD-10-CM.
MAIN OUTCOMES AND MEASURES Monthly rates of individuals with at least 1 diagnosis in a
diagnostic classification category per 10 000 eligible members.
RESULTS The analytic sample contained information on 2.1 billion enrollee person-months with 3.4
billion clinically assigned diagnoses; the mean (range) monthly sample size was 22.1 (18.4 to 27.1 )
million individuals. While diagnostic category prevalence changed minimally for WHO disease
chapters, the ICD-10-CM transition was associated with level changes of 20% or more among 20 of
127 HHS-HCCs (15.7%) and 46 of 282 AHRQ-CCS categories (16.3%) and with trend changes of 20%
or more among 12 of 127 of HHS-HCCs (9.4%) and 27 of 282 of AHRQ-CCS categories (9.6%). For
HHS-HCCs, monthly rates of individuals with any acute myocardial infarction diagnosis increased
131.5% (95% CI, 124.1% to 138.8%), primarily because HHS added non–ST-segment–elevation
myocardial infarction diagnoses to this category. The HHS-HCC for diabetes with chronic
complications increased by 92.4% (95% CI, 84.2% to 100.5%), primarily from including new
diabetes-related hypoglycemia and hyperglycemia codes, and the rate for completed pregnancy with
complications decreased by 54.5% (95% CI, –58.7% to –50.2%) partly due to removing vaginal birth
after cesarean delivery as a complication.
(continued)
Key Points
Question Was the transition from
International Classification of Diseases,
Ninth Revision, Clinical Modification
(ICD-9-CM) to the Tenth Revision (ICD-
10-CM) in October 2015 associated with
changes in diagnostic category
prevalence when diagnoses are grouped
by classification system?
Findings This interrupted time series
analysis and cross-sectional study
examined insurance claims for more
than 18 million privately insured adults
and children in the US from 2010 to
2017 and found instantaneous increases
or decreases of 20% or more associated
with the ICD-10-CM transition for nearly
1 in 6 (16%) diagnostic categories in 2
of 3 influential diagnostic
classification systems.
Meaning These findings suggest that
diagnostic classification systems
developed with ICD-9-CM data may
need to be refined for use with
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Abstract (continued)
CONCLUSIONS AND RELEVANCE These findings suggest that the ICD-10-CM transition was
associated with large prevalence changes for many diagnostic categories. Diagnostic classification
systems developed using ICD-9-CM may need to be refined using ICD-10-CM data to avoid
unintended consequences for disease surveillance, performance assessment, and risk-adjusted
payments.
JAMA Network Open. 2020;3(4):e202280. doi:10.1001/jamanetworkopen.2020.2280
Introduction
Diagnostic codes are widely used within health care in the US for reimbursement, quality
assessment, public health reporting, calculating risk-adjusted payments, and studying clinical
outcomes. In October 2015, the US switched its diagnostic coding system from the International
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to the more detailed
International Statistical Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM),
expanding the number of available codes nearly 5-fold.1 Previous studies have noted discontinuities
in specific disease or population subgroups.2-8 This interrupted time series analysis and cross-
sectional study sought to quantify the magnitude of change in prevalence in all diagnostic categories
for 3 widely used diagnostic classification systems and to explore potential reasons for these changes
through selected clinical review.
Methods
Data and Study Sample
We used the IBM MarketScan Commercial Database from January 1, 2010, to December 31, 2017,
including individuals ages 0 to 64 years enrolled in noncapitated commercial insurance plans with
both medical and pharmacy benefits. The MarketScan database contains deidentified health care
claims information from US employers, health plans, and hospitals. Data on all enrollment records
and inpatient, outpatient, ancillary, and drug claims are collated and linked to individuals. The age
and sex distribution of the eligible population varied little over the 96 months studied. Boston
University’s institutional review board exempted this study from review and informed consent owing
to the use of deidentified data. Data were analyzed from December 1, 2018, to January 21, 2020.
Outcome
Our primary outcome was the monthly rate of individuals with at least 1 diagnosis in a diagnostic
classification category per 10 000 enrollees. We used claim dates of service, health care practitioner
type, and inpatient and outpatient procedure codes to identify claims that are allowed to contribute
diagnostic codes, mimicking Department of Health and Human Services (HHS) filters used in risk
adjustment, which only consider diagnoses from an acceptable health care practitioner claim type:
hospital inpatient, hospital outpatient, or professional.9 Monthly prevalence rates were examined for
changes in reported diagnostic category prevalence at and following the October 2015 ICD-10-CM
transition.
Diagnostic Classification Systems
There were 14 567 allowable ICD-9-CM codes in 2015 vs 71 486 allowable ICD-10-CM codes in 2017 to
describe patient medical conditions.10 To reduce complexity, predictive models and disease tracking
systems rely on classification systems (ie, groupers) to collapse these codes into a smaller number of
broadly homogeneous clinical categories. We explored 3 commonly used classification systems.
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The World Health Organization (WHO) maps codes into chapters, which are commonly used for
epidemiology and surveillance, based on their first 3 alphanumeric characters. The WHO’s ICD-9-CM
mapping had 19 chapters, which expanded to 21 chapters with the transition to ICD-10-CM by
separating previously grouped eye, ear, and neurological disorders into distinct chapters. To facilitate
cross-year comparisons, we maintained the 19-chapter structure.11
The HHS Hierarchical Condition Categories (HHS-HCCs) system was developed for the Patient
Protection and Affordable Care Act (ACA) marketplace risk adjustment payment model and is used to
allocate funds among competing health plans.12 The HHS-HCC system used 127 condition categories
for the ACA population when it was implemented from 2014 through 2017, and its mappings were
updated to accommodate ICD-10-CM diagnoses in 2015.13 To ensure that recently added diagnostic
codes were recognized, we applied the 2017 HHS-HCC software to the full range of study data for
2010 to 2017. For sensitivity analysis, we evaluated the effects of the HHS filtering logic and the 2015
HHS software with the original ICD-10-CM mappings.
The Agency for Healthcare Research and Quality Clinical Classification System (AHRQ-CCS)
categories are used by managed care plans, insurers, researchers, and surveillance systems for
payment, quality assessment, and epidemiology. Its categories are also widely used for risk
adjustment and examining disease trends.14,15 The AHRQ-CCS largely maintained its category
structure with the transition to ICD-10-CM, and we used its 282 diagnostic categories appearing in our
data before and after the transition applying the 2017 category mappings.
All 3 classification systems updated their diagnostic categories to accommodate ICD-10-CM.16-18
However, because only 5% of ICD-9-CM codes can be mapped 1-to-1 to ICD-10-CM19 and the
crosswalk algorithms were developed before ICD-10-CM coding was adopted for clinical care, it was
not possible to prospectively examine the continuity of diagnostic categories across the transition.
For comparability across classification systems, we generated the condition categories described by
Kautter et al12 but did not impose the hierarchies used in the HHS-HCC model.
Statistical Analysis
To derive the monthly diagnostic category prevalence rates, we first applied HHS software filters9 to
calendar months based on the earliest service date of each claim line. We then standardized monthly
disease prevalence to eliminate variation based on the number of days in the month. In each month,
we counted the number of distinct individuals with any diagnosis code in a category, divided by the
number of people enrolled in that month, and multiplied by 30.437 (the mean number of days in a
month) per day in the month. This upweights prevalence rates in short months, such as February and
September, by between 1.5% and 8.7% and downweights 31-day months, such as October, by 1.8%.
We also examined trends in available population descriptors: sample size, age, sex, preferred
provider organization and health maintenance organization enrollment, and fraction in California
(the state with the largest representation in our sample). This confirmed that no large changes in the
study population occurred during our study period (eFigure 1 in the Supplement). Therefore, we
conducted all analyses without controlling for these variables.
We used piecewise linear regression models to examine level and trend changes in standardized
monthly diagnostic category prevalence associated with the October 2015 ICD-10-CM transition for
each diagnostic category in all 3 classification systems. All regressions included time (to model
secular trends), a post–ICD-10-CM indicator variable to estimate any immediate level change
associated with the ICD-10-CM transition, a 2-way interaction term to determine whether the
ICD-10-CM transition was associated with a change in trend, and dummy variables for each month to
control for seasonality (eAppendix in the Supplement).
We conducted statistical significance tests for all diagnostic categories in each classification
system. However, in this article, we focus attention on 3 common conditions: diabetes, cardiac
disease, and pregnancy. Within each condition we selected 3 HHS-HCC categories that illustrate a
range of observed patterns and chose clinically similar WHO chapters and AHRQ-CCS categories for
comparison.
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Statistical Tests
We used 2-sided t tests to identify statistically significant changes in level or trend in regression
results and F tests to look for the joint significance of level and trend changes. We performed 2 F tests
for each diagnostic category: one to test the hypothesis of a straight line with no change in October
2015 (ie, test of linearity), and the other to test whether the predicted diagnostic category
prevalence in December 2017 differed from a prediction based on extending the straight line fit to
pre–ICD-10-CM data (ie, cumulative effect of changes in level and time trend).
For all tests, we applied the Bonferroni multiple-testing correction20 so that P values were
considered statistically significant only when they were less than .05 divided by the number of
categories in the classification system. For example, in HHS-HCC regressions, statistical significance
required P < .0004 (ie, .05/127) for statistical significance in F tests. We considered changes of 20%
or more to be large.
Each monthly rate was calculated on more than 18 million individuals, making them extremely
precise. However, each statistical test examined changes in time using 96 observations. A significant
finding indicates that inclusion of a level or slope change at October 2015 describes the temporal
pattern in the observed data better than a straight line.
Data Interpretation and Visualization
To facilitate meaningful comparisons of changes across condition categories with vastly different
mean prevalence, we normalized all findings by dividing rates by the mean diagnostic category
prevalence from September 2015, the month prior to the ICD-10-CM transition. To visualize patterns
of observed changes, we created time series graphs for all diagnostic categories in each classification
system. Each graph depicts 3 normalized series: (1) observed diagnostic category prevalence, (2)
piecewise linear model predicted prevalence, and (3) locally estimated scatterplot smoothing curves,
fit separately to the pretransition and posttransition periods. This last series helps to visualize
possible nonlinear trends. While raw (ie, nonnormalized) rates were used for regression modeling
and testing, we describe these changes as percentages to focus on their size relative to the base rate
in September 2015.
Clinical Review
We used clinical review to explore potential reasons for large changes at the time of transition from
ICD-9-CM to ICD-10-CM for diabetes-, cardiac-, and pregnancy-related conditions in the examined
classification systems. For each HHS-HCC and AHRQ-CCS condition category with a statistically
significant change of 20% or more in prevalence level or trend that was selected for clinical review,
we examined frequencies of individual ICD-9-CM and ICD-10-CM diagnoses before and after the
ICD-10-CM transition. We also reviewed guidance documents for hospital coding staff regarding
changes in coding practices related to the ICD-10-CM transition for these diagnostic categories.
Results
The analytic sample contained information on 2.1 billion enrollee person-months with 3.4 billion
clinically assigned diagnoses; the mean (range) monthly sample size was 22.1 (18.4 to 27.1) million
individuals. The transition from ICD-9-CM was effectively instantaneous, with 99.8% of all diagnoses
coded using ICD-10-CM in October 2015.
We examined study population characteristics by month from 2010 through 2017 to look for
changes that might have introduced trend artifacts (eFigure 1 in the Supplement). Although the
number of eligible enrollees varied by year, population characteristics remained nearly constant
across all months. In particular, no noteworthy changes in the number of eligible enrollees, mean age,
sex, health insurance plan type, or fraction of enrollees located in California occurred at the October
2015 transition to ICD-10-CM. The proportion of enrollees with at least 1 eligible diagnosis in a month
was consistent over the sample period.
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Table 1 summarizes overall findings on changes in diagnostic category prevalence rates within
each classification system. No large changes were observed in the WHO chapters, suggesting that
overall coding practice (and population health) was relatively stable across the transition. However,
the F test rejects simple linearity in favor of a model with a discontinuity in slope or trend for 11 of 17
WHO chapters (58%), identifying small changes at the ICD-10-CM transition but none that
approached the threshold that we considered large (ie, 20%) .
In contrast, changes of 20% or more were common under the HHS-HCC and AHRQ-CCS
systems: statistically significant and large changes in level were found for 20 of 127 HHS-HCCs
(15.7%) and 46 of 282 AHRQ-CCS categories (16.3%). Large changes in trend occurred in 12 of 127
HHS-HCCs (9.4%) and 27 of 282 AHRQ-CCS categories (9.6%). Given the hundreds of categories in
the HHS and AHRQ classification systems, we selected a subset of categories relating to diabetes,
cardiac disease, and pregnancy to illustrate some of the largest discontinuities for the HHS-HCC
system. Tables summarizing regression results for all diagnostic categories in each classification
system are presented in eTable 1 in the Supplement for the WHO chapters, eTable 2 in the
Supplement for HHS-HCCs, and eTable 3 in the Supplement for AHRQ-CCS categories.
Table 2 summarizes results for 9 selected HHS-HCCs. Using regressions with 96 monthly
observations, we found large level changes in October 2015 for diabetes with chronic complications
(92.4% [95% CI, 84.2% to 100.5%]) and without chronic complications (−19.1% [95% CI, −25.3% to
−12.9%]), acute myocardial infarction (AMI) (131.5% [95% CI, 124.1% to 138.8%]), unstable angina
and other acute ischemic heart disease (−31.6% [95% CI, −37.5% to −25.7%]), and pregnancies with
major complications (−44.6% [95% CI, −53.8% to −35.4%]) and with complications (−54.5% [95%
CI, −58.7% to −50.2%]). We also found large changes in trend in diabetes with acute complications
(24.4% [95% CI, 11.7% to 37.1%]) and chronic complications (23.7% [95% CI, 11.7% to 35.7%]) and in
pregnancies with major complications (19.5% [95% CI, 6.0% to 33.0%]). There were large
cumulative effects of level and trend changes in 7 of the 9 selected HCCs, with the 3 largest being
AMI (147.4% [95% CI, 138.6% to 156.1%]), diabetes with chronic complications (116.1% [95% CI,
106.4% to 125.8%]), and completed pregnancy with complications (−50.8% [95% CI, −55.9% to
−45.7%]).
Figure 1 shows monthly diagnostic category prevalence over time for all diabetes-related
categories in all 3 classification systems. Figure 1A reveals that the number of individuals with at least
1 code for an endocrine system diagnosis continued its previous upward trend across the ICD-10-CM
transition. Figure 1B and C illustrate the immediate level changes in October 2015 for the HHS-HCC
system: lower for diabetes without complications and higher for diabetes with chronic complications.
There were no large changes in the AHRQ-CCS categories for diabetes with complications or diabetes
without complications at the ICD-10-CM transition.
Clinical review revealed that level changes in HHS-HCCs were largely explained by new codes in
ICD-10-CM that explicitly link certain conditions to diabetes. For example, in ICD-9-CM, an individual
separately coded as having diabetes and hypoglycemia would not necessarily be tagged as having
Table 1. Changes in Monthly Prevalence of Diagnostic Categories After International Statistical Classification
of Diseases, Tenth Revision, Clinical Modification by Classification System
Change
No. (%)
WHO chapters (n = 19)
Categories
HHS-HCC (n = 127) AHRQ-CCS (n = 282)a
Large changesb
Level 0 20 (15.7) 46 (16.3)
Trend 0 12 (9.4) 27 (9.6)
Cumulative by
20% or more 0 30 (23.6) 61 (21.6)
50% or more 0 12 (9.4) 28 (9.9)
F test rejected a straight line 11 (58) 74 (58.3) 165 (58.5)
Abbreviations: AHRQ-CCS, Agency for Healthcare
Research and Quality Clinical Classification System;
HHS-HCC, Department of Health and Human Services
Hierarchical Condition Category; WHO, World Health
Organization.
a Three AHRQ-CCS categories with 0 cases under
ICD-10-CM were excluded.
b Large changes were defined as an increase or
decrease by 20% or more.
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diabetes with complications. However, the HHS-HCC system maps the single ICD-10-CM code for
diabetes with hypoglycemia to a diabetes complication category, reducing the number of individuals
classified as having diabetes without complications.
Figure 2 depicts monthly diagnostic category prevalence rates for 6 selected cardiac diagnostic
categories. The HHS-HCC system showed a decline in unstable angina and other acute ischemic heart
disease and an increase in AMI. In contrast, there were no meaningful changes in AMI or its broader
category, coronary atherosclerosis and other heart disease, using the AHRQ-CCS system. Likewise,
there were no changes in prevalence among congestive heart failure categories in either the
HHS-HCC or AHRQ-CCS systems, or for the broad WHO chapter grouping diseases of the circulatory
system (eFigure 2 in the Supplement).
Clinical review found that the differences between trends in AMI within the HHS-HCCs and AHRQ-
CCS categories are largely explained by how these systems accommodated the ICD-10-CM non–ST-
elevation myocardial infarction (non-STEMI) diagnoses: the HHS-HCC system started mapping non-
STEMI codes into its AMI category in 2015, while AHRQ-CCS had already done so previously.
Figure 3 shows monthly diagnostic category prevalence rates for 6 selected pregnancy-related
categories. Additional pregnancy-related categories are included in eFigure 3 in the Supplement. We
found no change overall in the broad WHO chapter including complications of pregnancy, childbirth,
and the puerperium (eFigure 3 in the Supplement), nor for pregnancies without complications in the
HHS-HCC or AHRQ-CCS systems. The AHRQ-CCS system had a large negative level change in other
complications of birth (−58.8% [95% CI, −62.6% to −55.0%]) and an increase in other complications
of pregnancy (66.6% [95% CI, 61.3% to 71.9%]). No other pregnancy categories examined in the
AHRQ-CCS system had large changes in level or trend (eFigure 3 in the Supplement).
Our clinical review noted that the number of obstetrical codes doubled in ICD-10-CM vs
ICD-9-CM and that the ICD-10-CM coding system was restructured to remove designation of
antepartum, delivery, and postpartum status and to add separate codes to indicate weeks of
Table 2. Changes in Prevalence Levels and Trends Since ICD-10-CM Implementation for Selected HHS-HCCs
Condition categories HHS-HCC code
Prevalence/10 000 enrollees
in September 2015 (95% CI)a
Change since ICD-10-CM, % (95% CI) [P value]a
Level changeb Time trend effectc
Cumulative effect of level
and time trendd
Diabetes
With acute complications CC19 0.89 (0.84 to 0.94) 2.8 (−5.8 to 11.4)
[.26]
24.4 (11.7 to 37.1)
[<.001]
27.2 (16.9 to 37.5)
[<.001]
With chronic complications CC20 27.52 (27.25 to 27.79) 92.4 (84.2 to 100.5)
[<.001]
23.7 (11.7 to 35.7)
[<.001]
116.1 (106.4 to 125.8)
[<.001]
Without complication CC21 116.77 (116.21 to 117.33) −19.1 (−25.3 to −12.9)
[<.001]
−7.6 (−16.7 to 1.4)
[.005]
−26.7 (−34.1 to −19.4)
[<.001]
Cardiac disease
Congestive heart failure CC130 11.82 (11.64 to 12) 4.1 (−1.9 to 10.6)
[.02]
−5.6 (−14.9 to 3.6)
[.04]
−1.3 (−8.8 to 6.2)
[.56]
Acute myocardial infarction CC131 0.88 (0.83 to 0.93) 131.5 (124.1 to 138.8)
[<.001]
15.9 (5.1 to 26.7)
[<.001]
147.4 (138.6 to 156.1)
[<.001]
Unstable angina and other acute
ischemic heart disease
CC132 2.85 (2.76 to 2.94) −31.6 (−37.5 to −25.7)
[<.001]
−7.5 (−16.1 to 1.2)
[.004]
−39.1 (−46.1 to −32.0)
[<.001]
Completed pregnancy
With major complications CC207 0.40 (0.37 to 0.43) −44.6 (−53.8 to −35.4)
[<.001]
19.5 (6.0 to 33.0)
[<.001]
−25.1 (−36.1 to −14.1)
[<.001]
With complications CC208 5.17 (5.05 to 5.29) −54.5 (−58.7 to −50.2)
[<.001]
3.7 (−2.6 to 9.9)
[.046]
−50.8 (−55.9 to −45.7)
[<.001]
With no or minor complications CC209 12.40 (12.22 to 12.58) 2.8 (−0.2 to 5.9)
[.002]
−3.3 (−7.8 to 1.1)
[.01]
−0.4 (−4.0 to 3.2)
[.67]
Abbreviations: HHS-HCC, Health and Human Services Hierarchical Condition Category;
ICD-10-CM, International Statistical Classification of Diseases, Tenth Revision, Clinical
Modification.
a All 95% CIs are adjusted using the Bonferroni correction for multiple tests.
b Calculated as the coefficient on a dummy indicator for implementation of ICD-10-CM,
normalized by the base rate.
c Calculated based on the post–ICD-10-CM indicator interacted with time and shows the
change during 26 months after implementation of ICD-10-CM.
d Calculated as the level change and the time trend effect over the 26 months since
ICD-10-CM.
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gestation for ongoing pregnancies or pregnancy results for individuals who are no longer pregnant.
Among HHS-HCCs, some conditions, such as breech presentation and previous cesarean delivery,
were removed from the category for completed pregnancies with complications, contributing to
declines in the prevalence of these diagnostic categories. In contrast, the AHRQ-CCS system adapted
to the increased detail and restructuring of the obstetrical codes by adding many more specific codes
to its existing categories, resulting in abrupt increases in their prevalence at the ICD-10-CM transition.
Findings from sensitivity analyses were broadly consistent with the main analyses. These
included using monthly counts of diagnoses in each category as the primary outcome, not using the
HHS filtering logic, and substituting the 2015 HHS-HCC software for the 2017 version to set the
diagnostic category mappings.
Discussion
Our interrupted time series analysis and cross-sectional study of commercial claims from 2010 to
2017 revealed striking changes in levels and trends for many diagnostic categories associated with
Figure 1. Monthly Diagnostic Category Prevalence Rates of Diabetes Stratified by Classification System
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the transition to ICD-10-CM. Only small changes in levels or trends were found for the WHO disease
chapters, while 16% of HHS-HHCs and AHRQ-CCS categories displayed large and significant level
changes, while 9% to 10% displayed large changes in trend.
Our clinical review found that abrupt level changes were largely due to different decisions about
which codes to include or exclude in post–ICD-10-CM diagnostic categories, such as diabetes coded
jointly with hypoglycemia or hyperglycemia leading to a complicated diabetes category, non-STEMI
being included (or not) in the AMI category, and breech presentation leading to classification (or not)
as a complication of pregnancy. We also identified some changes in coding instructions and coding
practice that may have affected disease prevalence trend rates. Many ICD-10-CM codes have no
corresponding ICD-9-CM code. For certain conditions, the new, more specific ICD-10-CM codes were
rarely used in 2015 and 2016 but began to appear more regularly in 2017. For example, the strong
upward trend in diabetes with acute and chronic complications is partially due to increasing use of
codes for drug or chemical induced diabetes not available in ICD-9-CM. Likewise, refined codes, such
Figure 2. Monthly Diagnostic Category Prevalence Rates of Selected Cardiac Conditions Stratified
by Classification System
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as STEMI myocardial infarction of anterior wall (available starting in 2016), only began to appear in
2017, and many new codes for preeclampsia introduced in 2015 were infrequently used before 2017.
Our findings have important implications for interpreting differences in billing-code-derived
disease prevalence over time. For epidemiology, it is critical to distinguish between changes in actual
disease prevalence and changes in coding behaviors and mappings, which are often responsible for
observed changes in coded prevalence. We have seen that 3 separate, widely used classification
systems made different distinctions that affected apparent diagnostic category prevalence. Given
that HHS payment formulas rely on the prevalence of HCC categories to set billions of dollars in
payments, our finding of many large (artifactual) changes in diagnostic category prevalence has
potentially large implications for reimbursement.
Although HHS-HCCs are used for the ACA’s marketplace risk adjustment payments, this study
did not examine financial outcomes. Because the ACA uses risk adjustment to reallocate the available
funds among plans in a given region rather than to decide on the size of the funds available (as is done
in Medicare Advantage and Part D), changes in diagnostic category prevalence may have had less
Figure 3. Monthly Diagnostic Category Rates of Selected Pregnancy-Related Conditions Stratified
by Classification System
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financial effect in the marketplace than in Medicare Advantage. Classifications used for bonus or
performance evaluation are also vulnerable to large changes in level or trend when preexisting ICD-9-
CM–derived formulas are used across the ICD-10-CM transition. In addition, claims-based analyses of
disease prevalence may also be misleading if changes in the underlying classification system are not
recognized.
Our study used the earliest mappings accommodating all valid 2017 diagnoses for the included
classification systems. In 2019, the WHO, HHS, and AHRQ released new classification systems with
expanded diagnostic categories designed for 2019 diagnoses.17,21,22 Future research will need to
examine changes under these new systems. In the meantime, it is important to understand the
current mappings that will continue to be used to set payments and evaluate performance for several
more years.
Limitations
This study has several limitations. First, we only examined the association of diagnostic category
prevalence with the ICD-10-CM transition for individuals younger than 65 years who were privately
insured by employer-sponsored insurance, a population mostly enrolled in relatively generous health
plans. Coding patterns and discontinuities in frequencies of diagnostic categories may not generalize
to individuals covered by other insurers (eg, the ACA marketplace, Medicare, and Medicaid). Many
health care practitioners have been encouraged by their institutions to maximize the capture of
patient complexity in their billing. However, our study data came from commercial plans whose
payments are rarely risk adjusted for disease prevalence. Specifically, their payments do not generally
rely on HHS-HCCs, reducing the explicit incentive to increase the prevalence of well-reimbursed
HHS-HCC categories. Second, we did not examine changes at the ICD-10-CM transition on coding for
particular conditions for specific patients or in category prevalence based on other sources of
diagnoses, such as electronic medical records. Third, we used a piecewise linear model to look for
changes in level and trend, but for some categories in which diagnostic category prevalence trends
are not linear, our model may find changes at the transition when a nonlinear model would not.
Conclusions
The findings of this interrupted time series analysis and cross-sectional study suggest that the
transition to ICD-10-CM in October 2015 was associated with changes in levels and trends for most
diagnostic categories in 3 common diagnostic classification systems. While the broad categories used
in WHO disease chapters showed only small changes at the transition, numerous large changes (ie,
20%) in diagnostic category prevalence occurred in the more detailed HHS-HCCs and AHRQ-CCS
categories. These 2 classification systems have been widely adopted by health care organizations
for many purposes. Given the frequent, large discontinuities in diagnostic category prevalence rates
that we identified, predictive models and diagnostic category mappings developed for ICD-9-CM
should be refined for ICD-10-CM data to avoid unintended consequences for health care payment,
performance assessment, or disease surveillance.
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